Axa XL Man on the Run to raise funds for cancer charity
Hundreds of men are expected to hit the streets of Warwick for the Axa XL Man on the Run 5K on Sunday.
With categories available from the ages of seven upwards, there is still expected to be stiff competition despite the absence of Sean Trott and Adam Prunty, the island’s top male runners.
Philip Woolins, Will Green and Will Ellison are will be among the favourites among the seniors but could face strong challenges the up-and-coming athletes Dylan Eiselt, Adam Cenzer and Sanchez Smith.
The Axa XL Man on the Run 5K provides an opportunity for men to combine fitness and purpose. On a unique course starting and finishing at Warwick Academy, this event draws male participants of all ages from across Bermuda for a meaningful cause.
Clifford Roberts, the Man on the Run committee chairman, spoke on the significance of the event.
“This race is important because, since its inception, the number of participants has continued to grow,” Roberts said.
“More men are not only taking part but also talking openly about getting checked. The fear surrounding prostate exams is starting to fade, early prevention leads to early detection, men listen to your body.”
According to the organisers, Roberts came up with the event after seeing women speaking openly about their experience at breast cancer events. He wanted to create a men-only community event devoted to encouraging all men to become more conscious of their personal health and break down taboos around prostate cancer.
Proceeds from the race are all donated to Bermuda Cancer and Health Centre, with the funds are used to support local men’s health initiatives including cancer prevention.
“The Axa XL Man on the Run is an opportunity for men to lace up for a good cause,” said Deborah Titterton Narraway, the chief marketing and fundraising officer at Bermuda Cancer and Health Centre.
“By participating, men can make a positive impact by helping others access our services, whether it be through free men’s health screening events to life-saving screening and treatment.”
